News

FDA approves ketamine product for surgical pain management

The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.

FDA Approves Ketamine Product, KETARx, for Surgical Pain Management

By Lori Solomon HealthDay ReporterMONDAY, Aug. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

FDA's new expert panels are rife with financial conflicts and fringe views

A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its ...

Credible scientists can’t hold up Kennedy’s charade for much longer

Nonetheless, Kennedy is still in charge of the entire department, and it is likely only a matter of time until he resumes ...
MedPage Today4h

Semaglutide Gets FDA Greenlight for MASH

The glucagon-like peptide-1 (GLP-1) receptor agonist gained accelerated approval for patients with MASH and moderate to ...

FDA Approves Novo Nordisk’s Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease ...

Time is running out for kids with a rare disease, parents say, unless the FDA acts

After a more than decade-long process to bring the experimental drug elamipretide to market, the treatment’s approval has ...

FDA Issues Urgent Recall of Popular Coffee Over Dangerous Risk

FDA Issues Urgent Recall of Popular Coffee Over Dangerous Risk originally appeared on Men's Fitness. Instant coffee lovers should take caution after this nationwide recall. Dollar General has issued a ...
MPR2h

FDA Grants Breakthrough Tx Status to Ifinatamab Deruxtecan for Pretreated ES-SCLC

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ifinatamab deruxtecan for the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC) ...

Vanda Shares Rise, Court Overturns FDA Rejection of Jet Lag Treatment

Shares of Vanda rose after a federal appeals court overturned the FDA's rejection of the company's jet lag drug Hetlioz. The stock was up 6.5% to $4.65 on Monday, but is still down 11% so far this ...